Low False-Positive Rate of Aneuploidy Detection Using Fetal Cells Isolated from Maternal Blood

Sorry, there is no abstract. Read the first few lines of the text instead! Since 1994, the National Institutes of Health have funded the National Institute of Child Health and Human Development Fetal Cell Isolation Study (NIFTY), which is a clinical evaluation having the overall goal of comparing the accuracy of cytogenetic prenatal diagnosis by analyzing fetal cells isolated from maternal blood with results obtained by chorionic villus sampling or amniocentesis [1]. Four programs, several of which are multi-institutional, have participated in the development of common protocols and data analysis were performed.